| scholarly article | Q13442814 |
| P50 | author | Tadaaki Yamada | Q55070023 |
| P2093 | author name string | David P Carbone | |
| Joseph M Amann | |||
| Kyungho Park | |||
| Cynthia D Timmers | |||
| Jacob M Kaufman | |||
| P2860 | cites work | Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma. | Q36814030 |
| A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma. | Q36927481 | ||
| LKB1 is necessary for Akt-mediated phosphorylation of proapoptotic proteins | Q36999520 | ||
| A landscape of pharmacogenomic interactions in cancer. | Q37140236 | ||
| Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation | Q37274568 | ||
| Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer | Q37331472 | ||
| MEK inhibition in non-small cell lung cancer | Q38254501 | ||
| Heightening Energetic Stress Selectively Targets LKB1-Deficient Non-Small Cell Lung Cancers | Q38819110 | ||
| LKB1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKT. | Q38994951 | ||
| Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis | Q39659924 | ||
| MultiRankSeq: multiperspective approach for RNAseq differential expression analysis and quality control | Q40727604 | ||
| Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells | Q42478581 | ||
| LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition | Q43188970 | ||
| TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions | Q21999527 | ||
| COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer | Q24608391 | ||
| Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors | Q24614112 | ||
| Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations | Q24632064 | ||
| The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress | Q24633606 | ||
| Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks | Q24633890 | ||
| Three-stage quality control strategies for DNA re-sequencing data | Q26864378 | ||
| Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities | Q27345462 | ||
| A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response | Q27851728 | ||
| Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study | Q27851971 | ||
| Comprehensive molecular profiling of lung adenocarcinoma | Q28244995 | ||
| The LKB1 tumor suppressor negatively regulates mTOR signaling | Q28272728 | ||
| Uncoupling of the LKB1-AMPKalpha energy sensor pathway by growth factors and oncogenic BRAF | Q28474973 | ||
| Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2 | Q28509303 | ||
| Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation | Q28730029 | ||
| Apoptosis Induction by MEK Inhibition in Human Lung Cancer Cells Is Mediated by Bim | Q28749134 | ||
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity | Q29547693 | ||
| Systematic identification of genomic markers of drug sensitivity in cancer cells | Q29547695 | ||
| The LKB1-AMPK pathway: metabolism and growth control in tumour suppression | Q29617506 | ||
| LKB1 modulates lung cancer differentiation and metastasis | Q30080027 | ||
| Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset. | Q30384542 | ||
| Multi-perspective quality control of Illumina exome sequencing data using QC3. | Q30794236 | ||
| FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis | Q34504786 | ||
| Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. | Q34546258 | ||
| mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling | Q35581650 | ||
| LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin | Q36630561 | ||
| Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells | Q36782414 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 153-163 | |
| P577 | publication date | 2016-11-07 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | A Transcriptional Signature Identifies LKB1 Functional Status as a Novel Determinant of MEK Sensitivity in Lung Adenocarcinoma | |
| P478 | volume | 77 |
| Q48015155 | Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma |
| Q47592558 | Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations. |
| Q57232070 | Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma |
| Q97529523 | Regulation of cancer cell metabolism: oncogenic MYC in the driver's seat |
| Q47151535 | STK38L kinase ablation promotes loss of cell viability in a subset of KRAS-dependent pancreatic cancer cell lines |
| Q57810318 | Sorafenib in Combination with Betulinic Acid Synergistically Induces Cell Cycle Arrest and Inhibits Clonogenic Activity in Pancreatic Ductal Adenocarcinoma Cells |
| Q92297313 | Targeting metabolism to regulate immune responses in autoimmunity and cancer |
Search more.